Circulating tumour DNA (ctDNA) is transforming how we diagnose and treat complex cancers, particularly when clinical pathways ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

Exclusive: DNA test means patients could be offered most effective treatment first, boosting their chances of beating the disease ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

Circulating tumor DNA (ctDNA) is a blood test that looks for tiny pieces of cancer DNA released by dying cells, allowing doctors to detect cancer using a simple blood sample, Dr. Nicholas Hornstein ...

Scientists have developed a blood test that can help predict which breast cancer treatment will work best. The team at the ...

The largest study to date to assess the clinical value of concurrently testing tissue and circulating tumour DNA (ctDNA), highlights the usefulness of this dual approach for identifying targetable ...

AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today commented on recent updates by the NCCN on circulating tumor DNA (ctDNA) ...

FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a new study in Clinical Cancer Research, a ...

SAN FRANCISCO -- Circulating tumor DNA (ctDNA) measurements showed promise for identifying patients with early colorectal cancer (CRC) most likely to benefit from adjuvant therapy, analyses of two ...

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of a new study in Clinical Cancer Research, a journal of the American Association ...